According to our (Global Info Research) latest study, the global Integrilin Injection market size was valued at US$ 245 million in 2024 and is forecast to a readjusted size of USD 330 million by 2031 with a CAGR of 4.4% during review period.
Integrilin is a medication used in the field of cardiology and is classified as an antiplatelet agent. It is primarily indicated for the treatment of acute coronary syndrome (ACS) and is administered intravenously. Integrilin works by inhibiting platelet aggregation, which helps to prevent blood clots and reduce the risk of cardiac events in patients with ACS.
The market for Integrilin injection is driven by factors such as the prevalence of cardiovascular diseases, advancements in treatment options for ACS, and the need for effective antiplatelet therapies. Integrilin is commonly used in hospital settings, particularly in patients undergoing percutaneous coronary intervention (PCI) procedures or those with unstable angina or non-ST elevation myocardial infarction.
The global Integrilin injection market is influenced by factors such as the availability of alternative antiplatelet medications, reimbursement policies, and regional variations in the prevalence of cardiovascular diseases. North America and Europe have traditionally been significant markets for Integrilin, owing to well-established healthcare infrastructure and a high prevalence of cardiovascular diseases. The Asia-Pacific region also shows potential for market growth due to the increasing burden of cardiovascular diseases and improving healthcare access.
This report is a detailed and comprehensive analysis for global Integrilin Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Integrilin Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Integrilin Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Integrilin Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Integrilin Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Integrilin Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Integrilin Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include USV Private Limited, Teva Parenteral Medicines, Inc., Takeda, Sagent Pharmaceuticals, Baxter International Inc., Accord Healthcare Inc, Hybio Pharmaceutical Co., Ltd., Hainan Shuangcheng Pharma, Hainan Poly Pharm Co., Ltd, Nanjing King-friend Biochemical Pharmaceutical Co.,Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Integrilin Injection market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
0.75mg/ml
2mg/mL
Market segment by Application
Hospital
Clinic
Others
Major players covered
USV Private Limited
Teva Parenteral Medicines, Inc.
Takeda
Sagent Pharmaceuticals
Baxter International Inc.
Accord Healthcare Inc
Hybio Pharmaceutical Co., Ltd.
Hainan Shuangcheng Pharma
Hainan Poly Pharm Co., Ltd
Nanjing King-friend Biochemical Pharmaceutical Co.,Ltd.
Merck
Jiangsu Hansoh Pharmaceutical
Jiangsu Nuotai Ao Sanuo Biopharmaceutical
Hainan Zhonghe Pharmaceutical
Chengdu Shengnuo Biotechnology
Shenzhen Hanyu Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Integrilin Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Integrilin Injection, with price, sales quantity, revenue, and global market share of Integrilin Injection from 2020 to 2025.
Chapter 3, the Integrilin Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Integrilin Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Integrilin Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Integrilin Injection.
Chapter 14 and 15, to describe Integrilin Injection sales channel, distributors, customers, research findings and conclusion.
- 1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Integrilin Injection Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 0.75mg/ml
- 1.3.3 2mg/mL
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Integrilin Injection Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Others
- 1.5 Global Integrilin Injection Market Size & Forecast
- 1.5.1 Global Integrilin Injection Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Integrilin Injection Sales Quantity (2020-2031)
- 1.5.3 Global Integrilin Injection Average Price (2020-2031)
- 2 Manufacturers Profiles
- 2.1 USV Private Limited
- 2.1.1 USV Private Limited Details
- 2.1.2 USV Private Limited Major Business
- 2.1.3 USV Private Limited Integrilin Injection Product and Services
- 2.1.4 USV Private Limited Integrilin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 USV Private Limited Recent Developments/Updates
- 2.2 Teva Parenteral Medicines, Inc.
- 2.2.1 Teva Parenteral Medicines, Inc. Details
- 2.2.2 Teva Parenteral Medicines, Inc. Major Business
- 2.2.3 Teva Parenteral Medicines, Inc. Integrilin Injection Product and Services
- 2.2.4 Teva Parenteral Medicines, Inc. Integrilin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 Teva Parenteral Medicines, Inc. Recent Developments/Updates
- 2.3 Takeda
- 2.3.1 Takeda Details
- 2.3.2 Takeda Major Business
- 2.3.3 Takeda Integrilin Injection Product and Services
- 2.3.4 Takeda Integrilin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 Takeda Recent Developments/Updates
- 2.4 Sagent Pharmaceuticals
- 2.4.1 Sagent Pharmaceuticals Details
- 2.4.2 Sagent Pharmaceuticals Major Business
- 2.4.3 Sagent Pharmaceuticals Integrilin Injection Product and Services
- 2.4.4 Sagent Pharmaceuticals Integrilin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 Sagent Pharmaceuticals Recent Developments/Updates
- 2.5 Baxter International Inc.
- 2.5.1 Baxter International Inc. Details
- 2.5.2 Baxter International Inc. Major Business
- 2.5.3 Baxter International Inc. Integrilin Injection Product and Services
- 2.5.4 Baxter International Inc. Integrilin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.5.5 Baxter International Inc. Recent Developments/Updates
- 2.6 Accord Healthcare Inc
- 2.6.1 Accord Healthcare Inc Details
- 2.6.2 Accord Healthcare Inc Major Business
- 2.6.3 Accord Healthcare Inc Integrilin Injection Product and Services
- 2.6.4 Accord Healthcare Inc Integrilin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.6.5 Accord Healthcare Inc Recent Developments/Updates
- 2.7 Hybio Pharmaceutical Co., Ltd.
- 2.7.1 Hybio Pharmaceutical Co., Ltd. Details
- 2.7.2 Hybio Pharmaceutical Co., Ltd. Major Business
- 2.7.3 Hybio Pharmaceutical Co., Ltd. Integrilin Injection Product and Services
- 2.7.4 Hybio Pharmaceutical Co., Ltd. Integrilin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.7.5 Hybio Pharmaceutical Co., Ltd. Recent Developments/Updates
- 2.8 Hainan Shuangcheng Pharma
- 2.8.1 Hainan Shuangcheng Pharma Details
- 2.8.2 Hainan Shuangcheng Pharma Major Business
- 2.8.3 Hainan Shuangcheng Pharma Integrilin Injection Product and Services
- 2.8.4 Hainan Shuangcheng Pharma Integrilin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.8.5 Hainan Shuangcheng Pharma Recent Developments/Updates
- 2.9 Hainan Poly Pharm Co., Ltd
- 2.9.1 Hainan Poly Pharm Co., Ltd Details
- 2.9.2 Hainan Poly Pharm Co., Ltd Major Business
- 2.9.3 Hainan Poly Pharm Co., Ltd Integrilin Injection Product and Services
- 2.9.4 Hainan Poly Pharm Co., Ltd Integrilin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.9.5 Hainan Poly Pharm Co., Ltd Recent Developments/Updates
- 2.10 Nanjing King-friend Biochemical Pharmaceutical Co.,Ltd.
- 2.10.1 Nanjing King-friend Biochemical Pharmaceutical Co.,Ltd. Details
- 2.10.2 Nanjing King-friend Biochemical Pharmaceutical Co.,Ltd. Major Business
- 2.10.3 Nanjing King-friend Biochemical Pharmaceutical Co.,Ltd. Integrilin Injection Product and Services
- 2.10.4 Nanjing King-friend Biochemical Pharmaceutical Co.,Ltd. Integrilin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.10.5 Nanjing King-friend Biochemical Pharmaceutical Co.,Ltd. Recent Developments/Updates
- 2.11 Merck
- 2.11.1 Merck Details
- 2.11.2 Merck Major Business
- 2.11.3 Merck Integrilin Injection Product and Services
- 2.11.4 Merck Integrilin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.11.5 Merck Recent Developments/Updates
- 2.12 Jiangsu Hansoh Pharmaceutical
- 2.12.1 Jiangsu Hansoh Pharmaceutical Details
- 2.12.2 Jiangsu Hansoh Pharmaceutical Major Business
- 2.12.3 Jiangsu Hansoh Pharmaceutical Integrilin Injection Product and Services
- 2.12.4 Jiangsu Hansoh Pharmaceutical Integrilin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.12.5 Jiangsu Hansoh Pharmaceutical Recent Developments/Updates
- 2.13 Jiangsu Nuotai Ao Sanuo Biopharmaceutical
- 2.13.1 Jiangsu Nuotai Ao Sanuo Biopharmaceutical Details
- 2.13.2 Jiangsu Nuotai Ao Sanuo Biopharmaceutical Major Business
- 2.13.3 Jiangsu Nuotai Ao Sanuo Biopharmaceutical Integrilin Injection Product and Services
- 2.13.4 Jiangsu Nuotai Ao Sanuo Biopharmaceutical Integrilin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.13.5 Jiangsu Nuotai Ao Sanuo Biopharmaceutical Recent Developments/Updates
- 2.14 Hainan Zhonghe Pharmaceutical
- 2.14.1 Hainan Zhonghe Pharmaceutical Details
- 2.14.2 Hainan Zhonghe Pharmaceutical Major Business
- 2.14.3 Hainan Zhonghe Pharmaceutical Integrilin Injection Product and Services
- 2.14.4 Hainan Zhonghe Pharmaceutical Integrilin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.14.5 Hainan Zhonghe Pharmaceutical Recent Developments/Updates
- 2.15 Chengdu Shengnuo Biotechnology
- 2.15.1 Chengdu Shengnuo Biotechnology Details
- 2.15.2 Chengdu Shengnuo Biotechnology Major Business
- 2.15.3 Chengdu Shengnuo Biotechnology Integrilin Injection Product and Services
- 2.15.4 Chengdu Shengnuo Biotechnology Integrilin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.15.5 Chengdu Shengnuo Biotechnology Recent Developments/Updates
- 2.16 Shenzhen Hanyu Pharmaceutical
- 2.16.1 Shenzhen Hanyu Pharmaceutical Details
- 2.16.2 Shenzhen Hanyu Pharmaceutical Major Business
- 2.16.3 Shenzhen Hanyu Pharmaceutical Integrilin Injection Product and Services
- 2.16.4 Shenzhen Hanyu Pharmaceutical Integrilin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.16.5 Shenzhen Hanyu Pharmaceutical Recent Developments/Updates
- 3 Competitive Environment: Integrilin Injection by Manufacturer
- 3.1 Global Integrilin Injection Sales Quantity by Manufacturer (2020-2025)
- 3.2 Global Integrilin Injection Revenue by Manufacturer (2020-2025)
- 3.3 Global Integrilin Injection Average Price by Manufacturer (2020-2025)
- 3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Integrilin Injection by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Integrilin Injection Manufacturer Market Share in 2024
- 3.4.3 Top 6 Integrilin Injection Manufacturer Market Share in 2024
- 3.5 Integrilin Injection Market: Overall Company Footprint Analysis
- 3.5.1 Integrilin Injection Market: Region Footprint
- 3.5.2 Integrilin Injection Market: Company Product Type Footprint
- 3.5.3 Integrilin Injection Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
- 4 Consumption Analysis by Region
- 4.1 Global Integrilin Injection Market Size by Region
- 4.1.1 Global Integrilin Injection Sales Quantity by Region (2020-2031)
- 4.1.2 Global Integrilin Injection Consumption Value by Region (2020-2031)
- 4.1.3 Global Integrilin Injection Average Price by Region (2020-2031)
- 4.2 North America Integrilin Injection Consumption Value (2020-2031)
- 4.3 Europe Integrilin Injection Consumption Value (2020-2031)
- 4.4 Asia-Pacific Integrilin Injection Consumption Value (2020-2031)
- 4.5 South America Integrilin Injection Consumption Value (2020-2031)
- 4.6 Middle East & Africa Integrilin Injection Consumption Value (2020-2031)
- 5 Market Segment by Type
- 5.1 Global Integrilin Injection Sales Quantity by Type (2020-2031)
- 5.2 Global Integrilin Injection Consumption Value by Type (2020-2031)
- 5.3 Global Integrilin Injection Average Price by Type (2020-2031)
- 6 Market Segment by Application
- 6.1 Global Integrilin Injection Sales Quantity by Application (2020-2031)
- 6.2 Global Integrilin Injection Consumption Value by Application (2020-2031)
- 6.3 Global Integrilin Injection Average Price by Application (2020-2031)
- 7 North America
- 7.1 North America Integrilin Injection Sales Quantity by Type (2020-2031)
- 7.2 North America Integrilin Injection Sales Quantity by Application (2020-2031)
- 7.3 North America Integrilin Injection Market Size by Country
- 7.3.1 North America Integrilin Injection Sales Quantity by Country (2020-2031)
- 7.3.2 North America Integrilin Injection Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)
- 8 Europe
- 8.1 Europe Integrilin Injection Sales Quantity by Type (2020-2031)
- 8.2 Europe Integrilin Injection Sales Quantity by Application (2020-2031)
- 8.3 Europe Integrilin Injection Market Size by Country
- 8.3.1 Europe Integrilin Injection Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Integrilin Injection Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)
- 9 Asia-Pacific
- 9.1 Asia-Pacific Integrilin Injection Sales Quantity by Type (2020-2031)
- 9.2 Asia-Pacific Integrilin Injection Sales Quantity by Application (2020-2031)
- 9.3 Asia-Pacific Integrilin Injection Market Size by Region
- 9.3.1 Asia-Pacific Integrilin Injection Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Integrilin Injection Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)
- 10 South America
- 10.1 South America Integrilin Injection Sales Quantity by Type (2020-2031)
- 10.2 South America Integrilin Injection Sales Quantity by Application (2020-2031)
- 10.3 South America Integrilin Injection Market Size by Country
- 10.3.1 South America Integrilin Injection Sales Quantity by Country (2020-2031)
- 10.3.2 South America Integrilin Injection Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)
- 11 Middle East & Africa
- 11.1 Middle East & Africa Integrilin Injection Sales Quantity by Type (2020-2031)
- 11.2 Middle East & Africa Integrilin Injection Sales Quantity by Application (2020-2031)
- 11.3 Middle East & Africa Integrilin Injection Market Size by Country
- 11.3.1 Middle East & Africa Integrilin Injection Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Integrilin Injection Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)
- 12 Market Dynamics
- 12.1 Integrilin Injection Market Drivers
- 12.2 Integrilin Injection Market Restraints
- 12.3 Integrilin Injection Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
- 13 Raw Material and Industry Chain
- 13.1 Raw Material of Integrilin Injection and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Integrilin Injection
- 13.3 Integrilin Injection Production Process
- 13.4 Industry Value Chain Analysis
- 14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Integrilin Injection Typical Distributors
- 14.3 Integrilin Injection Typical Customers
- 15 Research Findings and Conclusion
- 16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
- 16.3 Disclaimer
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook